The number of people with susceptibility test result for rifampicin in Georgia
Georgia: The number of people with susceptibility test result for rifampicin was 99.79 in 2021. ▬ Flat
Latest (2021)
99.79
Change on year
down 0.0%
World rank
33rd
of 146 countries
All-time high
99.81
in 2020
All-time low
97.33
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Georgia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Georgia stood at 99.79.
That represents a change of up 1.5% over five years.
That places Georgia 33rd out of 146 countries with data for 2021, putting it in the top quarter.
The number of people with susceptibility test result for rifampicin in Georgia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 98.36 | — |
| 2018 | 97.33 | -1.0% |
| 2019 | 99.13 | +1.8% |
| 2020 | 99.81 | +0.7% |
| 2021 | 99.79 | -0.0% |
Georgia compared with similar countries
- Georgia's 99.79 is above the median for upper middle income countries, which is 92.7, 1.1× the median. (45 countries reporting)
- Georgia's 99.79 is above the median for Europe & Central Asia, which is 93.52, 1.1× the median. (43 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 98.27 | 97.33 | 99.13 | 3 |
| 2020s | 99.8 | 99.79 | 99.81 | 2 |
Countries ranked near Georgia
- 32 Kazakhstan 99.88 compare
- 34 Macau, China 98.97 compare
- 35 Singapore 98.69 compare
- 36 Norway 98.57 compare
More health data for Georgia
- Un projection of annual infant deaths, annual growth rate -3.7 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0382 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,310 deaths per 1,000 people (2090)
- Number of infants who die before age 1 26 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.2207 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0286 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.2812 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Georgia?
- The number of people with susceptibility test result for rifampicin in Georgia was 99.79 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Georgia?
- The highest recorded value was 99.81 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Georgia?
- The lowest recorded value was 97.33 in 2018.
- How does Georgia rank for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 33rd out of 146 countries with data for 2021.
- Where does this Georgia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).